Chunlin L Qian

US Patent:

20090240635, Sep 24, 2009

Filed:

Mar 18, 2009

Appl. No.:

12/381983

Inventors:

Chunlin Qian - Livingston NJ, US

International Classification:

G06Q 90/00

US Classification:

705500

Abstract:

A method for discovering new indications of any pharmaceutical product through systematically assessing the beneficial side effects of it directly from patients and their care takers in clinical trials, without first specifying what those effects might be. One embodiment of the method ensures that all collected beneficial side effects can be coded with a standard dictionary for adverse events, and that all important aspects of them are captured and summarized. The beneficial side effect data collected and analyzed will lead to more and faster discoveries of new indications and better understanding of pharmaceutical products. It is especially promising for diseases that are least understood or least researched. The standard animal-to-human drug research and development model does not work when a drug works in only humans, not animals. Such drugs can, however, be discovered through the method described here.